Michael Rogawski
Berater bei XENON PHARMACEUTICALS INC.
Profil
Michael A Rogawski is the founder of Marinus Pharmaceuticals, Inc., Epalex Corp.
He currently serves on the Scientific Advisory Board for Zogenix, Inc., Xenon Pharmaceuticals, Inc., and Catalio Capital Management LP.
He previously served on the Scientific Advisory Board for Aquestive Therapeutics, Inc., Zynerba Pharmaceuticals, Inc., and GW Pharmaceuticals Ltd.
He obtained his doctorate degree from Yale University.
Aktive Positionen von Michael Rogawski
| Unternehmen | Position | Beginn |
|---|---|---|
| XENON PHARMACEUTICALS INC. | Berater | - |
| ZOGENIX, INC. | Berater | - |
Catalio Capital Management LP
 Catalio Capital Management LP Investment ManagersFinance Catalio Capital Management LP (Catalio Capital) is a venture capital firm founded in 2020 by George Petrocheilos and Dr. Jacob Vogelstein. The firm is headquartered in New York. | Berater | - |
Epalex Corp.
 Epalex Corp. Miscellaneous Commercial ServicesCommercial Services Epalex Corp. engages in the development of novel treatments for migraine and epilepsy. The treatment for the first time provides a way for patients with epilepsy to gain control over their seizures. The firm also develops transformational products for seizure prophylaxis in patients suffering from primary generalized epilepsies. The company was founded Randall B. Murphy and is headquartered in Palo Alto, CA. | Gründer | - |
Ehemalige bekannte Positionen von Michael Rogawski
| Unternehmen | Position | Ende |
|---|---|---|
| ZYNERBA PHARMACEUTICALS, INC. | Berater | 10.10.2023 |
| AQUESTIVE THERAPEUTICS, INC. | Berater | - |
| GW PHARMACEUTICALS PLC | Berater | - |
| MARINUS PHARMACEUTICALS, INC. | Gründer | - |
Ausbildung von Michael Rogawski
| Yale University | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 4 |
|---|---|
| MARINUS PHARMACEUTICALS, INC. | Health Technology |
| AQUESTIVE THERAPEUTICS, INC. | Health Technology |
| ZYNERBA PHARMACEUTICALS, INC. | Health Technology |
| XENON PHARMACEUTICALS INC. | Health Technology |
| Private Unternehmen | 4 |
|---|---|
Zogenix, Inc.
 Zogenix, Inc. Pharmaceuticals: MajorHealth Technology Zogenix, Inc. is a pharmaceutical company. The firm engages in the development and commercialization of central nervous system (CNS) therapies and products for the treatment orphan diseases and other CNS disorders. Its products include Fintepla and MT1621. The company was founded by Stephen James Farr, Cam L. Garner, Roger L. Hawley, Bret E. Megargel, Jonathan M. N. Rigby, Scott L. Glenn, and John J. Turanin on May 11, 2006 and is headquartered in Emeryville, CA. | Health Technology |
GW Pharmaceuticals Ltd.
 GW Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology GW Pharmaceuticals Ltd. operates as an intermediate holding company and management company for investments in its subsidiaries. The company was founded by Geoffrey William Guy and Brian Whittle in 1998 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
Epalex Corp.
Epalex Corp. Miscellaneous Commercial ServicesCommercial Services Epalex Corp. engages in the development of novel treatments for migraine and epilepsy. The treatment for the first time provides a way for patients with epilepsy to gain control over their seizures. The firm also develops transformational products for seizure prophylaxis in patients suffering from primary generalized epilepsies. The company was founded Randall B. Murphy and is headquartered in Palo Alto, CA. | Commercial Services |
Catalio Capital Management LP
Catalio Capital Management LP Investment ManagersFinance Catalio Capital Management LP (Catalio Capital) is a venture capital firm founded in 2020 by George Petrocheilos and Dr. Jacob Vogelstein. The firm is headquartered in New York. | Finance |
